347 related articles for article (PubMed ID: 23716601)
21. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
Yun HJ; Kim JY; Kim G; Choi HS
Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
[TBL] [Abstract][Full Text] [Related]
22. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
23. Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity.
Helander S; Montecchio M; Pilstål R; Su Y; Kuruvilla J; Elvén M; Ziauddin JME; Anandapadamanaban M; Cristobal S; Lundström P; Sears RC; Wallner B; Sunnerhagen M
Structure; 2015 Dec; 23(12):2267-2279. PubMed ID: 26655473
[TBL] [Abstract][Full Text] [Related]
24. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.
Fan G; Fan Y; Gupta N; Matsuura I; Liu F; Zhou XZ; Lu KP; Gélinas C
Cancer Res; 2009 Jun; 69(11):4589-97. PubMed ID: 19458071
[TBL] [Abstract][Full Text] [Related]
25. Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.
D'Artista L; Bisso A; Piontini A; Doni M; Verrecchia A; Kress TR; Morelli MJ; Del Sal G; Amati B; Campaner S
Oncotarget; 2016 Apr; 7(16):21786-98. PubMed ID: 26943576
[TBL] [Abstract][Full Text] [Related]
26. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
Lucchetti C; Caligiuri I; Toffoli G; Giordano A; Rizzolio F
PLoS One; 2013; 8(2):e55355. PubMed ID: 23390529
[TBL] [Abstract][Full Text] [Related]
27. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
[TBL] [Abstract][Full Text] [Related]
28. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
[TBL] [Abstract][Full Text] [Related]
29. Pin1 promotes histone H1 dephosphorylation and stabilizes its binding to chromatin.
Raghuram N; Strickfaden H; McDonald D; Williams K; Fang H; Mizzen C; Hayes JJ; Th'ng J; Hendzel MJ
J Cell Biol; 2013 Oct; 203(1):57-71. PubMed ID: 24100296
[TBL] [Abstract][Full Text] [Related]
30. Skp2 regulates Myc protein stability and activity.
Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
[TBL] [Abstract][Full Text] [Related]
31. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
32. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
[TBL] [Abstract][Full Text] [Related]
33. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790
[TBL] [Abstract][Full Text] [Related]
34. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability.
Yeh ES; Lew BO; Means AR
J Biol Chem; 2006 Jan; 281(1):241-51. PubMed ID: 16223725
[TBL] [Abstract][Full Text] [Related]
35. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.
Wei S; Kozono S; Kats L; Nechama M; Li W; Guarnerio J; Luo M; You MH; Yao Y; Kondo A; Hu H; Bozkurt G; Moerke NJ; Cao S; Reschke M; Chen CH; Rego EM; Lo-Coco F; Cantley LC; Lee TH; Wu H; Zhang Y; Pandolfi PP; Zhou XZ; Lu KP
Nat Med; 2015 May; 21(5):457-66. PubMed ID: 25849135
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.
Monje P; Hernández-Losa J; Lyons RJ; Castellone MD; Gutkind JS
J Biol Chem; 2005 Oct; 280(42):35081-4. PubMed ID: 16123044
[TBL] [Abstract][Full Text] [Related]
37. Prolyl isomerase Pin1 shares functional similarity with phosphorylated CTD interacting factor PCIF1 in vertebrate cells.
Yunokuchi I; Fan H; Iwamoto Y; Araki C; Yuda M; Umemura H; Harada F; Ohkuma Y; Hirose Y
Genes Cells; 2009 Sep; 14(9):1105-18. PubMed ID: 19682092
[TBL] [Abstract][Full Text] [Related]
38. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
Endoh K; Nishi M; Ishiguro H; Uemura H; Miyagi Y; Aoki I; Hirano H; Kubota Y; Ryo A
Prostate; 2012 May; 72(6):626-37. PubMed ID: 21809350
[TBL] [Abstract][Full Text] [Related]
39. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
Girardini JE; Napoli M; Piazza S; Rustighi A; Marotta C; Radaelli E; Capaci V; Jordan L; Quinlan P; Thompson A; Mano M; Rosato A; Crook T; Scanziani E; Means AR; Lozano G; Schneider C; Del Sal G
Cancer Cell; 2011 Jul; 20(1):79-91. PubMed ID: 21741598
[TBL] [Abstract][Full Text] [Related]
40. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
